NC
MSGS icon

nVerses Capital’s Madison Square Garden MSGS Stock Holding History

nVerses Capital’s Portfolio MSGS Stock Details MSGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-700
Closed -$132K – 1258
2024
Q2 		$132K Buy
+700
New +$130K 0.08% 362

Other funds holding MSGS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Gates Foundation Trust
Gates Foundation Trust Kirkland, Washington $34.4B AUM 26.34% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

nVerses Capital's MSGS Position: Q3 2024 in Review

nVerses Capital sold out of Madison Square Garden (MSGS) in Q3 2024, closing a stake of 700 shares — an estimated $132K sold.

nVerses Capital first reported a position in MSGS in Q2 2024 and held it in 1 quarter. The position peaked at $132K in Q2 2024. 326 funds tracked by Wall St. Rank hold MSGS as of Q3 2024.

  • nVerses Capital reported no remaining Madison Square Garden position as of Q3 2024 after selling out during the quarter.
  • nVerses Capital sold 700 Madison Square Garden shares in Q3 2024, an estimated $132K.
  • nVerses Capital first reported a position in Madison Square Garden in Q2 2024 and held it in 1 quarter.
  • nVerses Capital's Madison Square Garden position peaked at $132K in Q2 2024.
  • 326 funds tracked by Wall St. Rank held Madison Square Garden as of Q3 2024.

Based on nVerses Capital's 13F filing for Q3 2024, filed 16 Oct 2024.